NCT06985199Enrolling by invitation
Culturally-adapted Mobile Health Intervention for Hypertension Care
AHOMKA Qualitative Study For Adaptation of the Medtronic Empower Health Platform
Source: ClinicalTrials.gov · Last updated 18 Jul 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
A single-arm study to assess the ability of the AHOMKA platform for hypertension management to affect blood pressure change among urban and rural patients in Ghana.
- Status (registry)
- Enrolling by invitation
- Study type
- Interventional
- Enrollment
- 160 (estimated)
- First submitted
- 14 May 2025
- Start date
- 31 Oct 2024
- Primary completion date
- 31 Jul 2025
- Lead sponsor
- Tufts University
- Diseases
- High blood pressure
- NCT number
- NCT06985199
What you commit to
- Study type: Interventional
- Planned participants: 160
- From 31 Oct 2024 to the primary completion date, 31 Jul 2025
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Comorbidities
Who the study is looking for
- diagnosis of hypertension
Age in the registry: 30 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| National Cardiothoracic Center Coordinator of this site? Confirm its status | Accra | Ghana | Unknown status |
| Cardiothoracic Center - Outpatient Department Coordinator of this site? Confirm its status | Ho | Ghana | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.